Matt Atwood, President and co-founder, started LoneStar MedTech with the purpose of finding natural alternatives to traditional medicines. Matt has an experienced thirty year background in medical manufacturing, medical distribution, corporate sales training, product branding and product development.
According to Matt, "The paradigm of modern medicine is changing back to natural alternatives. Patients are sick and tired of being sick and tired, and doctors Arte frustrated by the limited choices to offer their patients. We are here to fix that."
Matt is a gifted speaker who spends his time educating medical associations on natural alternative therapies like phytobiotics, stem cells/exosomes, and more.
Matt is also a Texas Farming advocate for the Texas hemp industry. MedTech's sister company AgriTech continues to work with state agencies such as the Texas Department of Agriculture, and Texas education such as Texas A&M AgriLife Research Center. These two verticals control the supply and the quality control for medical use.
"Bridging modern agriculture with natural medicine is a solution everyone is looking for. We couldn't find it, so we are making it."
Spike Humer is widely-recognized as a thought-leader and world-renowned expert in leading and inspiring companies, organizations, and individuals to achieve more, have more, and be more. He’s been called the “mentor’s mentor” and is highly regarded as a master marketing strategist and performance acceleration expert. Spike serves as a trusted advisor and performance consultant to entrepreneurs and individuals from virtually every walk-of-life and in countless industries, including medical cannabis.
He is an acclaimed author, speaker, thought-leader, and creator of “The 10 Day Turnaround Methodologies”, “Rapid Success Technologies”, and “The Overnight Entrepreneur” seminars, book, and workshop series.
Spike’s been a featured speaker at business seminars and life acceleration workshops around the world. He’s shared the stage and program platforms with such business luminaries and thought-leaders as Jack Welch, Prime Minister Tony Blair, Stephen Covey, Seth Godin, Mark Thompson, Jay Abraham, Brendon Burchard, Jack Canfield, Dr. Kevin Hogan, Mark Victor Hansen, Joe Sugarman, John Assaraf, Darren J. Stephens, Chet Holmes, and many others.
Jude Espinoza, MD, FACC is Board Certified in Internal Medicine and Cardiovascular Disease. He practices with South Texas Cardiology Specialists in San Antonio.
Dr. Espinoza considers it a calling to become a physician. After graduating with a degree in biomedical science from Texas A&M University in College Station, Texas, Dr. Espinoza pursued a medical degree at University of Texas Health Science Center at San Antonio, in San Antonio, Texas. He completed his residency in internal medicine at the University of Arkansas for Medical Sciences in Little Rock, Arkansas, where he gravitated toward cardiology early on.
In addition to serving as President of the American Heart Association - San Antonio from 2007 to 2016, Dr. Espinoza has held numerous appointments with local hospitals. He is a member of several professional organizations, including the American Medical Association, American College of Cardiology, American College of Physicians, Southside Chamber of Commerce and American Heart Association. Dr. Espinoza is board certified in internal medicine and cardiovascular disease.
Results-driven serial CIO leveraging emerging technologies for enterprise transformation. Diverse P&L leadership and experience delivering global growth while driving down operating costs. Executed several M&A deliveries, and implemented process and platform innovations. Demonstrated success developing growth drivers in life sciences, transportation, finance, and blockchain sectors.
Revolutionizing Life Sciences & Healthcare with Blockchain, AI & IoT
Rymedi's core offerings help life sciences sectors do what they do better, faster, cheaper.
Meanwhile, Rymedi Labs is developing innovations that enable life sciences industries to do things that were impossible or impractical prior to emerging blockchain, AI and IoT technologies.
Consulting with LoneStarLife Science Inc. for current and new product development. Assisting with formula corrections with their topical pain relief cream and consulting with safety, efficacy, and labeling requirements.
Responsibilities included patient medication reviews and data analysis of patients for numerous phase II and phase III clinical trials. Including statistically analysis, patient inclusion and exclusion criteria, and drug utilization review. Additionally, I participated on a team of researchers tasked with overcoming the drug stability and packaging requirements for Latisse® during phase III FDA review submittal.